Biobis-Pharma
Medical Cannabis
Health Tech & Life Sciences
Non Active, Mar 2023 ceased to operate
Company Overview
Snapshot
Founded in February 2018 by Ram Sarfaty and Ziv Eisner, Biobis-Pharma operates with 1–10 employees. The company ceased operations in March 2023.
Business overview
Biobis-Pharma specializes in providing cannabis solutions for pharmaceutical companies, drug developers, and retailers. The company focuses on delivering pharmaceutical-grade products by adhering to stringent standard operating procedures and methodologies common in the pharmaceutical and medical device industries. Biobis-Pharma leverages a global network of manufacturing facilities to ensure high availability and competitive cost structures for its clients, operating within the Health Tech & Life Sciences sector, specifically in Medical Cannabis.
Log in to access full profile ›Company Intelligence Q&A
- When was Biobis-Pharma founded?
- Biobis-Pharma was founded in February 2018.
- Who are the founders of Biobis-Pharma?
- The co-founders of Biobis-Pharma are Ram Sarfaty and Ziv Eisner.
- What is Biobis-Pharma's primary sector?
- Biobis-Pharma's primary sector is Health Tech & Life Sciences, with a focus on Medical Cannabis.
- What is the operational status of Biobis-Pharma?
- Biobis-Pharma is currently non-active, having ceased operations in March 2023.
- What kind of products does Biobis-Pharma offer?
- Biobis-Pharma offers pharmaceutical-grade cannabis solutions for pharmaceutical companies, drug developers, and retailers, emphasizing high-quality standards and competitive cost structures.